BR9908374A - Composition - Google Patents
CompositionInfo
- Publication number
- BR9908374A BR9908374A BR9908374-4A BR9908374A BR9908374A BR 9908374 A BR9908374 A BR 9908374A BR 9908374 A BR9908374 A BR 9908374A BR 9908374 A BR9908374 A BR 9908374A
- Authority
- BR
- Brazil
- Prior art keywords
- disease
- composition
- alzheimer
- amyloidogenic
- dementia
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 abstract 1
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 abstract 1
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 abstract 1
- 102000009091 Amyloidogenic Proteins Human genes 0.000 abstract 1
- 108010048112 Amyloidogenic Proteins Proteins 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 abstract 1
- 230000003942 amyloidogenic effect Effects 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"COMPOSIçãO" Formas de dosagem de liberação controlada úteis no tratamento e/ou profilaxia de demência, incluindo o mal de Alzheimer, em mamíferos, e para acentuar o processamento da proteína precursora de amilóide junto a um quadro não-amiloidogênico em pacientes que sofrem de, ou em risco de desenvolverem, o mal de Alzheimer."COMPOSITION" Controlled-release dosage forms useful in the treatment and / or prophylaxis of dementia, including Alzheimer's disease, in mammals, and to enhance the processing of the amyloid precursor protein together with a non-amyloidogenic picture in patients suffering from , or at risk of developing Alzheimer's disease.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7752798P | 1998-03-11 | 1998-03-11 | |
| PCT/EP1999/001557 WO1999045924A1 (en) | 1998-03-11 | 1999-03-05 | Composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9908374A true BR9908374A (en) | 2000-10-31 |
Family
ID=22138600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9908374-4A BR9908374A (en) | 1998-03-11 | 1999-03-05 | Composition |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BR9908374A (en) |
-
1999
- 1999-03-05 BR BR9908374-4A patent/BR9908374A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20092874L (en) | Prevention and treatment of amyloidogenic disease | |
| TR200002626T2 (en) | compound | |
| EA200400331A1 (en) | NEW CYCLOGEX SULPHONES | |
| BRPI0414435A (en) | methods and reagents for the treatment of immunoinflammatory disorders | |
| EA200101250A1 (en) | PREVENTION AND THERAPY OF AMYLOIDOGENIC DISEASE | |
| CL2010000018A1 (en) | Fragments of beta amyloid peptide (ab) ab 1-7 and ab 3-7 linked to a carrier peptide, a pharmaceutical composition that comprises it and its use to treat Alzheimer's disease | |
| DK2075007T3 (en) | Treatment of Alzheimer's disease | |
| EP0671920A4 (en) | An anti-idiotypic antibody and its use in diagnosis and in therapy in hiv-related disease. | |
| BR9609413A (en) | Dietary and pharmaceutical formulations for the prophylaxis and treatment of gastrointestinal disorders | |
| KR960700059A (en) | APPLICATION OF CARBAMAZEPINE AND OXCARBAZEPINE IN THE TREATMENT OF PARKINSON'S DISEASE AND PARKINSONIAN SYNDROMES) | |
| NO902280L (en) | NEW POROE'S PHARMACEUTICAL FORM AND MANUFACTURING THEREOF. | |
| BR0013353A (en) | Combination of active substance with clonidine | |
| ATE226447T1 (en) | ANTI-FAS ANTIBODIES AGAINST RHEUMATIC DISEASES | |
| DOP2002000451A (en) | NEW CYCLHEXILSULPHONES (THERAPEUTIC AGENTS) | |
| HUP9700806A2 (en) | Matrix tablet allowing the prolonged release of the sodium salt of tianeptine and process for the preparation thereof | |
| DE69031563D1 (en) | TREATMENT OF AUTOIMMUNE UVEORETINITIS IN PEOPLE | |
| TR200000455T2 (en) | The use of fanquinone in the treatment of Alzheimer's disease. | |
| ES2162520T3 (en) | MEDICATIONS BASED ON HYPERFORINE AND / OR HYPERFORINE EXTRACTS. | |
| BR9908374A (en) | Composition | |
| BRPI0210317B8 (en) | therapeutic vaccine complex for the prevention or treatment of leishmaniasis and infections mediated by intracellular pathogenic microorganisms in mammals | |
| ES2173977T3 (en) | USE OF R- (Z) -ALFA- (METOXIIMINO) -ALFA- (1-AZABICICLO (2.2.2) OCT-3-IL) ACETONITRILE TO REDUCE THE FORMATION OF AMILACEA BETA A4 PROTEIN IN THE DISEASE OF ALZHEIMER. | |
| TR199801798T2 (en) | Autism treatment. | |
| ES2188742T3 (en) | TRAPIDIL FOR USE IN THE THERAPY OF PATHOLOGICAL TABLES INFLUENCABLE BY IMMUNOMODULATION. | |
| BRPI0417796A (en) | effervescent preparation of a basic substance of medicinal effect | |
| RU97118990A (en) | NATURAL POLYVITAMIN COMPLEX "ASTENOTON" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTA A 6O, 7O E 8O ANUIDADES. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |